Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call

MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more

Eppendorf AG completes conversion to European public limited company

19.10.2021 Hamburg, October 2021 • Conversion to SE (“Societas Europaea”) completed • No impact on current business• Group headquarter remains in Hamburg, Germany The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE... Read more

Bruker Announces Date and Time of Third Quarter 2021 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2021 financial results on Monday, November 1, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can... Read more

Xylem to Release Third Quarter 2021 Financial Results on November 2, 2021

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 14, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its third quarter 2021 results at 6:55 a.m. (ET) on Tuesday, November 2, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more

SPT Labtech integrates recent acquisitions into unified brand and portfolio

12/10/2021 SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, unveils new branding that brings together its technologies with those from recent acquisitions into a single entity. The merged portfolio and positioning reflect SPT Labtech’s commitment to harnessing the ingenuity and product development track record... Read more

PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 7, 2021– PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. Qualified laboratories can immediately begin using this... Read more

EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization

Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 5, 2021– EUROIMMUN, a PerkinElmer, Inc. company (NYSE: PKI), announced today that the U.S. Food and Drug Administration has provided Emergency Use Authorization (EUA) for its Anti-SARS-CoV-2 S1 CurveTM ELISA (IgG). This assay allows... Read more

Illumina Expands Presence in Latin America

Sep 30, 2021 Opens Illumina entities in Colombia and México SAN DIEGO, Sept. 30, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced the creation of Illumina Colombia S.A.S. and Illumina México Productos de Biotecnología marking our commitment to expand genomics in Latin America and increase the level of support for our local customers and partners.  “Colombia... Read more